This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Tumeh JW, Shenoy PJ, Moore SG, Kauh J, Flowers C.A markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer. American Journal of Clinical Oncology 32: 49-55, No. 1, Feb 2009
Rights and permissions
About this article
Cite this article
FOLFOX, FOLFIRI show similar cost effectiveness in mCRC. Pharmacoecon. Outcomes News 573, 5 (2009). https://doi.org/10.2165/00151234-200905730-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905730-00015